Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
Funding Amount
Varies
Deadline
May 7, 2029
947 days left
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- State governments
- Small businesses
- Tribal organizations
- Nonprofits (501(c)(3))
- Nonprofits without 501(c)(3) status
- Special district governments
- For-profit businesses
- Public colleges & universities
Geography
- Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Overview
Biological Testing Facility for Contraception & Reproductive Health
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for access to a state-of-the-art Biological Testing Facility (BTF) for advancing both contraceptive and reproductive health-related product development. There is a critical need for fertility regulation methods that fit the needs of women and men throughout their reproductive lives, and it is also essential to support the development of new therapies related to reproductive health. Investigators with innovative and validated methods for future clinical development are encouraged to consider applying for this NOFO. This opportunity will use the X01 activity code, which the National Institutes of Health (NIH) uses to invite eligible institutions to seek access to NIH research resources. Grant authorities that allow the Eunice Kennedy Shriver National Institute of Child Health and Human Development to forecast this opportunity are as follows: Public Health Service Act, Section 301, 448 and 487, as amended, Public Laws 78-410 and 99-158, as amended, 42 U.S.C. 241; 42 U.S.C. 285g; 42 U.S.C. 288; Small Business Research and Development Enhancement Act of 1992, Public Law 102-564, Public Law 118-47. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop responsive projects.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: PAR-26-071
- Instrument: grant
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Focus Areas & Funding Uses
Fields of Work
- Reproductive health
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
National Institutes of Health
Amount
Varies
Deadline
October 3, 2026
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health
Amount
Varies
Deadline
October 6, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Ready to apply for Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed). Now let's win it.